Descargar PDF — Tromboembolismo venoso en los viajes prolongados y otras situaciones de Riesg… Tromboembolismo venoso en los viajes prolongados y otras situaciones de Riesgo. El síndrome de la clase turista. Dr. Oscar Vidal, Dr. Sergio Garbarz* Hospital Italiano de La Plata,*Fundación Flebológica Argentina. La posibilidad de sufrir un Tromboembolismo Venoso (TEV) luego de viajes…

Descarga: Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia Archivo: tromboembolia-venosa/tvp/th_2016-Clinical picture of HITand its differentiation from non-HIT thrombocytopenia.pdf HIT is an acquired antibody-mediated disorder strongly associated with thrombosis, including microthrombosis secondary to disseminated intravascular dissemination (DIC). The clinical features of HIT are reviewed from the perspective of the 4Ts scoring…

Descarga: Antithrombin: anti-inflammatory properties and clinical applications Archivo: tromboembolia-venosa/th_2016-Antithrombin anti-inflammatory properties and.pdf Many humoral and cellular components participate in bidirectional communication between the coagulation and inflammation pathways. Natural anticoagulant proteins, including antithrombin (AT), tissue factor pathway inhibitor, and protein C, suppress proinflammatory mediators. Conversely, inflammation blunts anticoagulant activity and, when uncontrolled, promotes systemic inflammation-induced coagulation,…

Descarga: Cancer-associated venous thromboembolism: Burden, mechanisms, and management Archivo: tromboembolia-venosa/tvp/th_2017-Cancer-associated venous thromboembolism.pdf Venous thromboembolism (VTE) is a significant health problem in the general population but especially in cancer patients. In this review, we discuss the epidemiology and burden of the disease, the pathophysiology of cancer-associated VTE, and the clinical treatment options for both primary prevention…

Descarga: Management of the multiple phases of heparin-induced thrombocytopenia Archivo: tromboembolia-venosa/tvp/th_2016-Management of the multiple phases of heparin-induced thrombocytopenia.pdf The clinical course of heparin-induced thrombocytopenia (HIT) may be separated into five sequential phases: 1. suspected HIT, 2. acute HIT, 3. subacute HIT A, 4. subacute HIT B, and 5. remote HIT. Each phase confronts the clinician…

Descarga: Clinical and laboratory tests for the diagnosis of heparin-induced thrombocytopenia Archivo: tromboembolia-venosa/tvp/th_2016-Clinical and laboratory tests for the diagnosis of heparin-induced thrombocytopenia.pdf A rapid diagnostic work-up is required in patients with suspected heparin-induced thrombocytopenia (HIT). However, diagnosis of HIT is challenging due to a number of practical issues and methodological limitations. Many laboratory tests and…

Descarga: Role of monocytes and endothelial cells in heparin-induced thrombocytopenia Archivo: tromboembolia-venosa/tvp/th_2016-Role of monocytes and endothelial cells in heparin-induced thrombocytopenia.pdf Heparin-induced thrombocytopenia (HIT) is an autoimmune disorder characterised by thrombocytopenia and thrombosis. The mechanisms leading to platelet destruction are complex and the thrombotic complications of HIT appear to be due to multiple different intravascular targets….

Descarga: Cirrhosis as a risk factor for venous thrombosis Archivo: tromboembolia-venosa/tvp/th_2017-Cirrhosis as a risk factor for venous thrombosis.pdf Chronic and acute liver diseases have long been considered as the epitome of acquired bleeding disorders. Evidence in support of this included profoundly abnormal test results of routine diagnostic tests of haemostasis in combination with clinical bleeding…